Avidity Biosciences

RNA | NASDAQ | 1 Obserwujący

$29.17

-0.65%

-$0.19

Obserwuj

Overview Metrics Financials

Fair Price

$85.17

Overvalued by 87.7%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Avidity Biosciences is a biotechnology company focused on developing advanced therapeutic methods using targeted RNA-based therapies. The company specializes in creating therapeutic products that leverage its proprietary technologies to selectively deliver therapeutic molecules to specific cells, offering a new approach to treating diseases caused by genetic mutations. Avidity focuses on treating diseases such as Duchenne muscular dystrophy and other genetic disorders that previously lacked effective treatments.

Feed

There are no posts to show right now.

Avidity Biosciences

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?